Leaderboards/T-cell and Retrovirus Studies

T-cell and Retrovirus Studies

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Alice Bexon
Unknown
97
2
Patrick M. Reagan
University of Rochester
93
3
Javier Segovia
Fundación Santa Fe de Bogotá
87
4
Anskar Y.H. Leung
Chinese University of Hong Kong
75
5
R. Alejandro Sica
Albert Einstein College of Medicine
73
6
Ricardo Amaru
Universidad Mayor de San Andrés
72
7
María Carolina Ceriani
Universidad Nacional del Centro de la Provincia de Buenos Aires
59
8
Christophe Nicot
University of Kansas Medical Center
59
9
Houshang Rafatpanah
Mashhad University of Medical Sciences
59
10
Roselene Ecco
Universidade Federal de Minas Gerais
59

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Bisma Shahbaz
Forman Christian College
99
2
Sizhen Wang
Nanjing General Hospital of Nanjing Military Command
92
3
Julia Werner
Heinrich Heine University Düsseldorf
91
4
Erin Kaser
The University of Texas at San Antonio Health Science Center
89
5
Shuai‐Shuai Ge
City Of Hope National Medical Center
89
6
Yufei Zhang
Houston Methodist
89
7
Timothy I. Shaw
Moffitt Cancer Center
89
8
Moonjung Jeun
Chungnam National University
89
9
Silvia Mancilla
Universidad Mayor de San Andrés
89
10
Florian Simon
Friedrich-Alexander-Universität Erlangen-Nürnberg
54

Emerging Leaders Papers

1
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Research Square|2024
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Steven A. Rosenberg
National Cancer Institute
99
2
Olivier Cassar
Institut Pasteur
96
3
Keiichi Fukuda
Keio University
96
4
Xuejun Jiang
Memorial Sloan Kettering Cancer Center
91
5
Gregg L. Semenza
Johns Hopkins University
88
6
Daniel Hwang
United States Department of Agriculture
87
7
Alain Fischer
Hôpital Necker-Enfants Malades
84
8
Kun‐Liang Guan
University of California, San Diego
76
9
David C. Chan
California Institute of Technology
75
10
Christopher C. Benz
Buck Institute for Research on Aging
68

All-Time Leaders Papers

1
mTOR: a pharmacologic target for autophagy regulation
Journal of Clinical Investigation|2015
2.1k cit.
2
Ferroptosis is an autophagic cell death process
Cell Research|2016
1.8k cit.
3
Mechanisms of Hippo pathway regulation
Genes & Development|2016
1.7k cit.
4
Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases
Human Molecular Genetics|2009
1.4k cit.
5
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
Genes & Development|2001
1.4k cit.
6
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Journal of Clinical Oncology|2008
1.3k cit.
7
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Journal of Clinical Investigation|2013
1.3k cit.
8
IL-2: The First Effective Immunotherapy for Human Cancer
The Journal of Immunology|2014
1.3k cit.
9
The Hippo pathway: regulators and regulations
Genes & Development|2013
1.2k cit.
10
Metabolic regulation of mitochondrial dynamics
The Journal of Cell Biology|2016
1.1k cit.

Reagents for T-cell and Retrovirus Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

Phospho-GSK-3 alpha (Ser21) (D1G2) Rabbit Monoclonal Antibody

Cited in 8 papers
#8452$176
View Evidence →Cell Signaling Technology

Phospho-CRMP-2 (Thr514) Antibody

Cited in 6 papers
#9397$362
View Evidence →Cell Signaling Technology

USP8 (D18F6) Rabbit Monoclonal Antibody

Cited in 5 papers
#11832$161
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Rb Control Proteins

Cited in 14 papers
#9303$163
View Evidence →Cell Signaling Technology

SimpleChIP® Mouse PER1 Intron 1 Primers

Cited in 10 papers
#13902$137
View Evidence →Cell Signaling Technology

MAPKAPK-5 (D70A10) Rabbit Monoclonal Antibody

Cited in 9 papers
#7419$161
View Evidence →